Literature DB >> 33506896

Circular RNA CircMTO1 suppressed proliferation and metastasis of osteosarcoma through miR-630/KLF6 axis.

D-Y Liu1, Z Li, K Zhang, N Jiao, D-G Lu, D-W Zhou, Y-B Meng, L Sun.   

Abstract

OBJECTIVE: Circular RNAs (circRNAs) could regulate gene expression which may induce tumor occurrence and progression. In the current study, we first investigated the expression of circMTO1 in osteosarcoma, and the underlying mechanism was further elucidated. PATIENTS AND METHODS: Circular RNA microarrays were used to identify the differential expression of circRNAs in osteosarcoma tissues and the corresponding normal tissues. qRT-PCR was used to examine the level of circMTO1 in osteosarcoma tissues and cell lines. In addition, circMTO1 overexpression was constructed using lentiviral transfection in cell lines. Subsequently, the Cell Counting Kit-8 (CCK8), cell migration and invasion, and flow cytometry were used to investigate the effect of circMTO1 on the biological functions of cells. The Western Blot and the recovery experiments were used to explore the potential mechanism.
RESULTS: Here, we measured 20 circRNAs which were downregulated in osteosarcoma tissues using circRNA microarray. CircMTO1 expression was decreased in osteosarcoma cell lines. Besides, circMTO1 could inhibit cell proliferation, migration and invasion, and induced apoptosis in osteosarcoma cells. Bioinformatics analysis showed that circMTO1 serves as a sponge for miR-630 and KLF6 is a direct target of miR-630. Furthermore, circMTO1 functions through regulation of miR-630/KLF6 axis.
CONCLUSIONS: Our study suggests circMTO1 could suppress osteosarcoma progression by regulating miR-630/KLF6 axis, which may highlight the diagnostic and therapeutic potential of these molecules in osteosarcoma treatment.

Entities:  

Year:  2021        PMID: 33506896     DOI: 10.26355/eurrev_202101_24352

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis.

Authors:  Yingying Chen; Ying Zhang
Journal:  Strahlenther Onkol       Date:  2022-06-24       Impact factor: 3.621

2.  Potential and functional prediction of six circular RNAs as diagnostic markers for colorectal cancer.

Authors:  Li Yuan Liu; Dan Jiang; Yuliang Qu; Hongxia Wang; Yanting Zhang; Shaoqi Yang; Xiaoliang Xie; Shan Wu; Haijin Zhou; Guangxian Xu
Journal:  PeerJ       Date:  2022-05-19       Impact factor: 3.061

Review 3.  Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.

Authors:  Jingyu Zhong; Guangcheng Zhang; Weiwu Yao
Journal:  J Orthop Surg Res       Date:  2021-10-07       Impact factor: 2.359

4.  Circular RNA MTO1 intercorrelates with microRNA-630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients.

Authors:  Zhihua Shi; Ye Wen; Senbing Zhang; Xin Cheng
Journal:  J Clin Lab Anal       Date:  2021-09-20       Impact factor: 2.352

5.  Circular RNA mitochondrial translation optimization 1 correlates with less lymph node metastasis, longer disease-free survival, and higher chemotherapy sensitivity in gastric cancer.

Authors:  Cheng Chang; Anrui Zheng; Pinfa Wang; Xiaojun Teng
Journal:  J Clin Lab Anal       Date:  2022-04-27       Impact factor: 3.124

Review 6.  The Roles of circMTO1 in Cancer.

Authors:  Wei Liu; Yuanyuan Xiong; Renhua Wan; Renfeng Shan; Jianfeng Li; Wu Wen
Journal:  Front Cell Dev Biol       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.